Back to Search Start Over

Recipient age and risk for mortality after kidney transplantation in England.

Authors :
Karim A
Farrugia D
Cheshire J
Mahboob S
Begaj I
Ray D
Sharif A
Source :
Transplantation [Transplantation] 2014 Apr 27; Vol. 97 (8), pp. 832-8.
Publication Year :
2014

Abstract

Background: The aim of this study was to explore age-related mortality post-kidney transplantation in England over the last decade.<br />Methods: This study used data from Hospital Episode Statistics to select all kidney transplant procedures performed in England between April 2001 and March 2012. Demographics and medical comorbidities (based upon ICD-10 codes) were extracted at baseline. Data linkage analysis was performed with the Office for National Statistics to identify all deaths occurring among this study cohort.<br />Results: Data for 19,103 kidney transplant procedures was analyzed, with a median follow-up of 4.4 years (interquartile range 2.2-7.3 years). Categorization of age cohorts at time of transplantation were age below 50 (n=11,421, 59.8%), 50 to 59 (n=4,195, 22.0%), 60 to 69 (n=2,887, 15.1%), 70 to 79 (n=589, 3.1%), and 80 and above (n=11, 0.1%). There were 2,085 deaths that occurred among the study cohort during follow-up and mortality risk increased with age: below 50 (5.8%), 50 to 59 (14.2%), 60 to 69 (22.0%), 70 to 79 (31.9%), and 80 and above (45.5%). The three most common causes of deaths for recipients 70 and over were cardiac (21.2%), infection (21.2%), and malignancy (20.2%), respectively. Lower mortality was observed with the receipt of a living-donor kidney for recipients aged 70 and above. On Cox regression analysis, risk for death increased with each additional decade of recipient age over 50.<br />Conclusion: Increasing age is a strong, independent risk factor for death after kidney transplantation. Although lower mortality was observed with living kidney transplantation among elderly recipients, living-donor rates decrease with increasing recipient age. Pretransplant counseling and posttransplant tailored immunosuppression should be explored, the latter requiring targeted clinical trials.

Details

Language :
English
ISSN :
1534-6080
Volume :
97
Issue :
8
Database :
MEDLINE
Journal :
Transplantation
Publication Type :
Academic Journal
Accession number :
24342978
Full Text :
https://doi.org/10.1097/01.TP.0000438026.03958.7b